Pfizer (PFE) Tops Q1 EPS by 2c, Revenues Miss; Reaffirmed Guidance

Pfizer (NYSE: PFE) reported Q1 EPS of $0.77, $0.02 better than the analyst estimate of $0.75. Revenue for the quarter came in at $12.9 billion versus the consensus estimate of $13.15 billion.

Reaffirmed All Components of 2018 Financial Guidance:

• Revenues: $53.5 to $55.5 billion
• Adjusted Diluted EPS: $2.90 to $3.

For earnings history and earnings-related data on Pfizer (PFE) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance
• Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer